Mounjaro 15mg Tirzepatide Injection

Mounjaro 15mg Tirzepatide Injection is an injectable medicine containing tirzepatide, a glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist, commonly known as a GIP and GLP-1 receptor agonist. It is a prescription medicine intended for use only under the supervision of a licensed healthcare professional.

Mounjaro provides a once-weekly injectable tirzepatide option for patients who are prescribed GIP/GLP-1 receptor agonist therapy. The 15mg strength is generally considered a high dose strength and may be used as part of a doctor-supervised treatment plan depending on response, tolerability, and clinical assessment. It should not be started, changed, or stopped without medical advice.

This product listing refers to 2 single-dose pens.

Product Information

• Product Name: Mounjaro 15mg Tirzepatide Injection
• Japanese Name: マンジャロ皮下注15mgアテオス
• Chinese Name: Mounjaro 15mg 替爾泊肽注射液（2 支單次劑量筆）
• Active Ingredient: Tirzepatide
• Strength: 15mg
• Pack Size: 2 single-dose pens
• Dosage Form: Subcutaneous injection pen
• Route of Administration: Subcutaneous
• Drug Class: GIP and GLP-1 receptor agonist
• Brand Owner: Eli Lilly and Company
• Product Type: Prescription medicine
• Use: Use only as directed by a licensed healthcare professional

What Is Mounjaro 15mg Tirzepatide Injection?

Mounjaro 15mg Tirzepatide Injection contains tirzepatide in a prefilled injection pen for subcutaneous administration. Tirzepatide belongs to a class of medicines that act on both GIP and GLP-1 receptors, which are involved in metabolic regulation, blood glucose response, insulin secretion, glucagon regulation, gastric emptying, appetite, and satiety signaling.

Mounjaro is administered by injection under the skin as directed by a healthcare professional. The exact dose, injection schedule, and treatment duration should be determined by a doctor based on the patient’s medical condition, treatment response, treatment stage, and tolerability.

This product should not be used without medical advice, diagnosis, and prescription.

Key Features

Mounjaro 15mg Tirzepatide Injection is known for:

• Contains tirzepatide 15mg
• Pack contains 2 single-dose pens
• Subcutaneous injection pen format
• Once-weekly administration as directed
• Dual GIP and GLP-1 receptor agonist
• Tirzepatide-based injectable option
• Used according to healthcare professional treatment plan
• Manufactured by Eli Lilly and Company
• Prescription-only medicine
• Should be used with medical monitoring and lifestyle guidance

About Tirzepatide

Tirzepatide is a GIP and GLP-1 receptor agonist. It works by activating receptors involved in glucose metabolism and appetite-related signaling.

Under healthcare professional guidance, tirzepatide may help support:

• Blood glucose management
• Insulin secretion response when blood glucose is elevated
• Reduced glucagon release when appropriate
• Slower gastric emptying
• Appetite and satiety-related signaling
• Overall metabolic care as part of a treatment plan

The effect and suitability of tirzepatide depend on each patient’s health condition, current medications, medical history, treatment goals, and doctor’s assessment.

Dose Strength Information

The 15mg strength is commonly used as the highest listed dose strength within a doctor-supervised tirzepatide treatment plan. It may be prescribed after previous lower-dose treatment, depending on tolerability and clinical response.

A healthcare professional may assess:

• Treatment response
• Side effects
• Blood glucose results
• Digestive tolerance
• Current dose history
• Other medications
• Overall health condition

Patients should not increase, decrease, or stop the dose without medical advice.

How to Use Mounjaro 15mg Tirzepatide Injection

Use exactly as directed by your doctor, pharmacist, or healthcare provider.

General administration guidance may include:

• Inject under the skin as directed.
• Common injection areas may include the abdomen, thigh, or upper arm.
• Use once weekly if prescribed.
• Use on the same day each week, unless otherwise instructed.
• Each pen is for single-dose use only.
• Do not inject into a vein or muscle.
• Rotate injection sites.
• Do not share injection pens with others.
• Follow your prescribed dosing schedule carefully.

Always follow the official prescription label, product instructions, and your healthcare provider’s guidance.

Who May Be Prescribed Mounjaro 15mg Tirzepatide Injection?

Mounjaro 15mg Tirzepatide Injection may be prescribed by a healthcare professional for suitable adult patients who need GIP/GLP-1 receptor agonist therapy as part of a medical treatment plan.

A doctor may assess:

• Medical history
• Blood sugar control
• Current treatment plan
• Previous response to incretin therapy
• Digestive system condition
• Kidney and liver function
• Pregnancy or breastfeeding status
• Risk of drug interactions
• Risk of hypoglycemia when used with insulin or sulfonylureas
• Ability to use injectable medication safely

This medicine is not suitable for everyone.

Important Safety Information

Before using Mounjaro 15mg Tirzepatide Injection, tell your healthcare provider if you:

• Have a history of pancreatitis
• Have severe stomach or intestinal problems
• Have kidney disease
• Have liver disease
• Have diabetic retinopathy
• Are pregnant, planning pregnancy, or breastfeeding
• Are taking insulin or sulfonylurea medicines
• Have a history of thyroid tumors or endocrine disorders
• Have allergies to tirzepatide or any ingredient in the injection
• Are taking other prescription or non-prescription medicines

Possible Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort
• Loss of appetite
• Indigestion
• Bloating
• Fatigue
• Injection site reaction

Serious side effects may occur rarely and require medical attention.

Seek medical help immediately if you experience:

• Severe or persistent abdominal pain
• Severe vomiting or dehydration
• Signs of pancreatitis
• Allergic reaction
• Vision changes
• Symptoms of low blood sugar, especially when used with insulin or sulfonylurea
• Neck lump, difficulty swallowing, or persistent hoarseness
• Severe injection site reaction

Storage

Store according to the product package and pharmacist instructions.

General storage recommendations:

• Keep in original packaging.
• Store refrigerated before first use if required by product instructions.
• Do not freeze.
• Protect from heat and direct sunlight.
• Keep away from children and pets.
• Do not use after the expiry date.
• Dispose of used pens safely according to local guidance.

Important Notes

• Mounjaro 15mg Tirzepatide Injection is a prescription medicine.
• This pack contains 2 single-dose pens.
• Use only under doctor supervision.
• Do not share this medicine or injection pens with others.
• Do not use for cosmetic weight loss without medical indication.
• Do not change dose without medical advice.
• It is not a substitute for diet, exercise, or diabetes care.
• Individual results and tolerability vary.

Disclaimer

This product page is for general product information only and does not replace professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.